Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of THDB0206 vs Humalog in Healthy Chinese Subjects
NCT06153329Phase 1Completed
- Sponsor
- Tonghua Dongbao
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BioChaperone Lispro in diabetes mellitus (DM) (3 arms), sponsored by Tonghua Dongbao. Primary endpoint: Area Under the Curve for Insulin Lispro from 0 to 30 minutes. Started Jun 2021; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06153329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153329.